CAPIVASERTIB vs CAPLACIZUMAB-YHDP: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
CAPIVASERTIB vs CAPLACIZUMAB-YHDP: Safety Overview
| Metric | CAPIVASERTIB | CAPLACIZUMAB-YHDP |
|---|---|---|
| Total FAERS Reports | 1,691 | 1,397 |
| Deaths Reported | 285 | 59 |
| Death Rate | 16.9% | 4.2% |
| Hospitalizations | 464 | 270 |
| Average Patient Age | 66.2 yrs | 46.1 yrs |
| % Female Patients | 94.6% | 70.4% |
| FDA Approval Date | Nov 16, 2023 | N/A |
| Manufacturer | AstraZeneca Pharmaceuticals LP | N/A |
| Route | ORAL | N/A |
| Marketing Status | Prescription | Prescription |